Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer von Peeters, M., Price, T.J., Cervantes, A., Sobrero, A.F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C.J.A., Strickland, A.H., Wilson, G., Ciuleanu, T.E., Roman, L., Van Cutsem, E., Tian, Y., Sidhu, R.

Volltext

Corrigendum: Comparative microbiome analysis of beef cattle, the feedyard environment, and airborne particulate matter as a function of probiotic and antibiotic use, and change in... von Strickland, A H, Murray, S A, Vinasco, J, Auvermann, B W, Bush, K J, Sawyer, J E, Scott, H M, Norman, K N

Volltext

Comparative microbiome analysis of beef cattle, the feedyard environment, and airborne particulate matter as a function of probiotic and antibiotic use, and change in pen environme... von Strickland, A H, Murray, S A, Vinasco, J, Auvermann, B W, Bush, K J, Sawyer, J E, Scott, H M, Norman, K N

Volltext

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma von Peeters, M, Strickland, A H, Lichinitser, M, Suresh, A V S, Manikhas, G, Shapiro, J, Rogowski, W, Huang, X, Wu, B, Warner, D, Jain, R, Tebbutt, N C

Volltext

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal ca... von Eatock, M.M., Tebbutt, N.C., Bampton, C.L., Strickland, A.H., Valladares-Ayerbes, M., Swieboda-Sadlej, A., Van Cutsem, E., Nanayakkara, N., Sun, Y.-N., Zhong, Z.D., Bass, M.B., Adewoye, A.H., Bodoky, G.

Volltext

Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer von Milat, F, Goh, S, Gani, L.U, Suriadi, C, Gillespie, M.T, Fuller, P.J, Teede, H.J, Strickland, A.H, Allan, C.A

Volltext

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab von Tebbutt, N.C., Murphy, F., Zannino, D., Wilson, K., Cummins, M.M., Abdi, E., Strickland, A.H., Lowenthal, R.M., Marx, G., Karapetis, C., Shannon, J., Goldstein, D., Nayagam, S.S., Blum, R., Chantrill, L., Simes, R.J., Price, T.J.

Volltext

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial von Tebbutt, N C, Parry, M M, Zannino, D, Strickland, A H, Van Hazel, G A, Pavlakis, N, Ganju, V, Mellor, D, Dobrovic, A, Gebski, V J

Volltext

Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemother... von Patel, G. S., Jain, K., Kumar, R., Strickland, A. H., Pellegrini, L., Slavotinek, J., Eaton, M., McLeay, W., Price, T., Ly, M., Ullah, S., Koczwara, B., Kichenadasse, G., Karapetis, C. S.

Volltext

A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer von Michael, M, Price, T, Ngan, S Y, Ganju, V, Strickland, A H, Muller, A, Khamly, K, Milner, A D, Dilulio, J, Matera, A, Zalcberg, J R, Leong, T

Volltext

A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma von Halford, S., Yip, D., Karapetis, C. S., Strickland, A. H., Steger, A., Khawaja, H. T., Harper, P. G.

Volltext

Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up von Karapetis, C. S., Strickland, A. H., Yip, D., Steer, C., Harper, P. G.

Volltext

PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis von Karapetis, C. S., Strickland, A. H., Yip, D., van der Walt, J. D., Harper, P. G.

Volltext

A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies von Yip, D., Karapetis, C., Strickland, A. H., Steer, C., Holford, C., Knight, S., Harper, P.

Volltext

Immunomodulation therapy in colorectal carcinoma von Yip, D., Strickland, A.H., Karapetis, C.S., Hawkins, C.A., Harper, P.G.

Volltext

Pathologic Splenic Rupture as the Presentation of Mantle Cell Lymphoma von Strickland, A. H., Marsden, K. A., McArdle, J., Lowenthal, R. M.

Volltext

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II tri... von Steer, C B, Chrystal, K, Cheong, K A, Galani, E, Marx, G M, Strickland, A H, Yip, D, Lofts, F, Gallagher, C, Thomas, H, Harper, P G

Volltext

Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience von Strickland, A H, Karapetis, C S, Yip, D, Harper, P G

Volltext

Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia von STRICKLAND, A. H., SEYMOUR, C., PRINCE, H. M., WOLF, M., JUNEJA, S., JANUSZEWICZ, E. H.

Volltext

Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies von Diakos, C.I., Tu, D., Gebski, V., Yip, S., Wilson, K., Karapetis, C.S., O'Callaghan, C.J., Shapiro, J., Tebbutt, N., Jonker, D.J., Siu, L.L., Wong, R., Doyle, C., Strickland, A.H., Price, T.J., Simes, J., Clarke, S.

Volltext